Uterine sarcoma

Uterine sarcoma- Mesenchymal tumor of uterus/bulky masses.

The uterine sarcomas form a group of malignant tumors that arises from the smooth muscle or connective tissue of the uterus.

## Contents

* 1 Signs and symptoms
* 2 Histology
* 3 Diagnosis
* 3.1 Classification
* 4 Management
* 5 Epidemiology
* 6 See also
* 7 References
* 8 External links

## Signs and symptoms[edit | edit source]

Unusual or postmenopausal bleeding may be a sign of malignancy including uterine sarcoma and needs to be investigated. Other signs include pelvic pain, pressure, and unusual discharge. A nonpregnant uterus that enlarges quickly is suspicious. However, none of the signs are specific. Specific screening test have not been developed; a Pap smear is a screening test for cervical cancer and not designed to detect uterine sarcoma.

## Histology[edit | edit source]

Tumoral entities include leiomyosarcomas, endometrial stromal sarcomas, carcinosarcomas and "other" sarcomas.[1]

* If the lesion originates from the stroma of the uterine lining it is an endometrial stromal sarcoma.
* If the uterine muscle cell is the originator the tumor is a uterine leiomyosarcoma.
* Carcinosarcomas comprise both malignant epithelial and malignant sarcomatous components.

## Diagnosis[edit | edit source]

Investigations by the physician include imaging (ultrasound, CAT scan, MRI) and, if possible, obtaining a tissue diagnosis by biopsy, hysteroscopy, or D&C. Ultimately the diagnosis is established by the histologic examination of the specimen. Typically malignant lesions have >10 mitosis per high power field. In contrast, a uterine leiomyoma as a benign lesion would have < 5 mitoses per high power field.

### Classification[edit | edit source]

Leiomyosarcomas are now staged using the 2009 FIGO staging system[2] (previously they were staged like endometrial carcinomas) at the time of surgery.

* Stage I: tumor is limited to the uterus

IA: ≤5 cm in greatest dimension
IB: >5 cm

* Stage II: tumor extends beyond the uterus, but within the pelvis

IIA: involves adnexa of uterus
IIB: involves other pelvic tissues

* Stage III: tumor infiltrates abdominal tissues

IIIA: 1 site
IIIB: >1 site
IIIC: regional lymph node metastasis

* Stage IVA: invades bladder or rectum
* Stage IVB: distant metastasis (including intra-abdominal or inguinal lymph nodes; excluding adnexa, pelvic and abdominal tissues)

Endometrial stromal sarcomas and uterine adenosarcomas are classified as above, with the exception of different classifications for Stage I tumors.

* Stage I: the tumor is limited to the uterus

IA: limited to endometrium/endocervix
IB: invades <½ myometrium
IC: invades ≥½ myometrium

Finally, malignant mixed Müllerian tumors, a type of carcinosarcoma, are staged similarly to endometrial carcinomas.[3]

* Stage I: the tumor is limited to the uterus

IA: invades <½ myometrium
IB: invades ≥½ myometrium

* Stage II: invades cervical stroma, but no extension beyond the uterus
* Stage III: local and/or regional spread

IIIA: invades uterine serosa and/or adnexa
IIIB: vaginal and/or parametrial involvement
IIIC: metastases to pelvic and/or paraaortic lymph nodes

IIIC1: positive pelvic nodes
IIIC2: positive para-aortic lymph nodes

* Stage IVA: invades bladder and/or bowel mucosa
* Stage IVB: distant metastases (including intra-abdominal metastases and/or inguinal lymph nodes)

## Management[edit | edit source]

Therapy is based on staging and patient condition and utilizes one or more of the following approaches. Surgery is the mainstay of therapy if feasible involving total abdominal hysterectomy with bilateral salpingo-oophorectomy. Other approaches include radiation therapy, chemotherapy, and hormonal therapy.

Prognosis is relatively poor.[4]

## Epidemiology[edit | edit source]

Uterine sarcoma is rare, out of all malignancies of the uterine body only about 4% will be uterine sarcomas.[5] Generally, the cause of the lesion is not known, however, patients with a history of pelvic radiation are at higher risk. Most tumors occur after menopause. Women who take long-term tamoxifen are at higher risk.[6]

## See also[edit | edit source]

* Uterine fibroids
* Leiomyosarcoma

## References[edit | edit source]

1. ↑ Zagouri F, Dimopoulos AM, Fotiou S, Kouloulias V, Papadimitriou CA (2009). "Treatment of early uterine sarcomas: disentangling adjuvant modalities". World J Surg Oncol. 7: 38. doi:10.1186/1477-7819-7-38. PMC 2674046. PMID 19356236.
2. ↑ "Archive copy". Archived from the original on 2020-06-14. Retrieved 2021-09-29.`{{cite web}}`: CS1 maint: archived copy as title (link)
3. ↑ "Endometrial Cancer Treatment". 1980-01-01. Archived from the original on 2014-04-06. Retrieved 2021-09-29.
4. ↑ Gadducci A, Cosio S, Romanini A, Genazzani AR (February 2008). "The management of patients with uterine sarcoma: a debated clinical challenge". Crit. Rev. Oncol. Hematol. 65 (2): 129–42. doi:10.1016/j.critrevonc.2007.06.011. PMID 17706430.
5. ↑ [1] Archived 2010-05-14 at the Wayback Machine American Cancer Society information, accessed 03-11-2006
6. ↑ [2] Archived 2015-04-08 at the Wayback Machine National Cancer Institute information, accessed 03-11-2006

## External links[edit | edit source]

* Leiomyosarcoma of the Uterus: A Review Archived 2012-06-15 at the Wayback Machine

* v
* t
* e

Tumors of the female urogenital system

Adnexa|

| Ovaries|

| Glandular and epithelial/
surface epithelial-
stromal tumor|

| CMS:|

* Ovarian serous cystadenoma
* Mucinous cystadenoma
* Cystadenocarcinoma
* Papillary serous cystadenocarcinoma
* Krukenberg tumor

|

* Endometrioid tumor
* Clear-cell ovarian carcinoma
* Brenner tumour

Sex cord–gonadal stromal|

* Leydig cell tumour
* Sertoli cell tumour
* Sertoli–Leydig cell tumour
* Thecoma
* Granulosa cell tumour
* Luteoma
* Sex cord tumour with annular tubules

Germ cell|

* Dysgerminoma
* Nongerminomatous
* Embryonal carcinoma
* Endodermal sinus tumor
* Gonadoblastoma
* Teratoma/Struma ovarii
* Choriocarcinoma

Fibroma|

* Meigs' syndrome

Fallopian tube|

* Adenomatoid tumor

Uterus|

| Myometrium|

* Uterine fibroids/leiomyoma
* Leiomyosarcoma
* Adenomyoma

|

Endometrium|

* Endometrioid tumor
* Uterine papillary serous carcinoma
* Endometrial intraepithelial neoplasia
* Uterine clear-cell carcinoma

Cervix|

* Cervical intraepithelial neoplasia
* Clear-cell carcinoma
* SCC
* Glassy cell carcinoma
* Villoglandular adenocarcinoma

Placenta|

* Choriocarcinoma
* Gestational trophoblastic disease

General|

* Uterine sarcoma
* Mixed Müllerian tumor

Vagina|

* Squamous-cell carcinoma of the vagina
* Botryoid rhabdomyosarcoma
* Clear-cell adenocarcinoma of the vagina
* Vaginal intraepithelial neoplasia
* Vaginal cysts

Vulva|

* SCC
* Melanoma
* Papillary hidradenoma
* Extramammary Paget's disease
* Vulvar intraepithelial neoplasia
* Bartholin gland carcinoma

*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template